Alira Health

Alira Health

Five Key Success Factors for Managing Transactions in Full Virtual Mode

Reports
Category:
Published on:
November 1, 2020
Written by:
Benjamin Chambon, Raphaël Metrop

It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.

Benjamin Chambon, Alira Health’s Executive Vice President, Transaction Advisory, and Raphael Metrop, Director, Transaction Advisory, give their insight into the keys to success in managing transactions in a full virtual mode in this newest infographic.

You can also learn more about our transaction advisory services.

For more information, please contact Raphael Metrop.

For more information about Alira Health’s Transaction Advisory services

Click here

Related news

Events October 6, 2022
The MedTech Conference 2022
We are pleased to share that we will be joining the MedTech Conference 2022 as sponsors and speakers! This year’s edition will have more than 100 sessions focusing on today’s hot topics.
M&A MedTech Regulatory
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. The financing was provided by key existing investors Creadev, an evergreen(...)
M&A MedTech Pharma Press Release
Articles August 3, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
Key questions to ask to help ensure that your next transaction advisory firm partnership is best positioned to achieve your goals.
M&A
News April 12, 2021
Alira Health Strengthens Growth Strategy with $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
M&A MedTech Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
M&A Pharma
News November 29, 2020
Alira Health as Strategic Advisor to Benvic in Acquisition Luc & Bel
We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.
CDMO M&A
Reports November 1, 2020
Five Key Success Factors for Managing Transactions in Full Virtual Mode
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
M&A
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.